Recent Articles from Investor Brand Network

Federal hemp regulations are set to shift dramatically in nine months, a change that industry leaders warn could effectively outlaw most consumable cannabinoid products. In the meantime, the FDA faces a looming deadline to provide guidance that could shape the future of hemp policy.

Disseminated on behalf of Numa Numa Resources Inc. and may include paid advertisements.

GridAI Technologies (NASDAQ: GRDX) is focused on advancing opportunities at the intersection of artificial intelligence and energy infrastructure following its acquisition of Grid AI, Inc. “The company recently announced that it had named Marshall Chapin as the CEO of the company’s GridAI, Inc. subsidiary,” an article discussing the company reads. “GridAI, Inc. is developing next-generation grid and power-management software for hyperscale artificial-intelligence (‘AI’) data-center campuses, providing an AI-driven energy orchestration platform that coordinates distributed energy resources across multiple scales. With the fast-growing AI-data-center market anticipated to reach $1 trillion by 2030, the need for intelligent power orchestration solutions has become critical… GridAI Inc.’s new CEO has decades of leadership experience across the grid-optimization, energy-transition, and distributed-energy sectors, and, since March 2025, Chapin has served as the Interim CEO of Amp X, an AI-driven grid-edge platform, which is also a GridAI subsidiary. His appointment shows GridAI’s commitment to deploying a top-of-the-line orchestration engine that’s able to manage the power and flexibility demands of the massive and growing AI data center market.”

Micropolis (NYSE American: MCRP) was featured in a recent article that discussed its efforts to expand its industrial robotics portfolio through unveiling a new platform designed for heavy-duty, continuous operations. “The platform was revealed in January at the UMEX 2026 exhibition in Abu Dhabi, where it was showcased on the stand of EDGE Group, the UAE’s state-backed advanced technology and defense manufacturer,” the publication reads. “The Autonomous Logistics Platform is built on Micropolis’ M01 base vehicle and is intended for use in controlled industrial settings rather than public roads. Target environments include manufacturing facilities, industrial zones, logistics corridors, and other secured or access-restricted areas where predictable routes and repeatable missions are critical. The company describes the system as a response to the growing need for reliable, autonomous transport of goods and equipment within large industrial campuses.”

Crypto markets are known for their speed, size, and surprises. But even in this fast-moving world, what happened at a South Korean crypto exchange shocked many people. A simple mistake turned into a $40 billion problem almost instantly.

After a staggering rally of nearly 150% last year, the price of silver has hit a particularly rough patch amid elevated market volatility that started last week. On Thursday alone, the price plunged nearly 20%. The rout started during early trading in the Asian markets and continued when U.S. markets opened.

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, is focused on enhancing established cancer therapies by targeting a fundamental biological pathway involved in tumor survival and resistance. “Rather than developing standalone treatments, LIXTE is advancing a first-in-class approach designed to increase the effectiveness of chemotherapy and immunotherapy across multiple cancer indications,” reads a recent article. “At the center of LIXTE’s strategy is protein phosphatase 2A, or PP2A, an enzyme that plays a critical role in regulating cell growth, DNA repair, and survival signaling. In many cancers, PP2A activity enables tumor cells to recover from the damage caused by treatment, contributing to resistance and disease progression… LIXTE’s proprietary compound, LB-100, is a small-molecule PP2A inhibitor designed to temporarily disrupt these repair mechanisms at the moment when cancer cells are exposed to therapy. Preclinical research cited in the company’s presentation shows that this disruption can make tumor cells more vulnerable to chemotherapy and immunotherapy, increasing treatment effectiveness without introducing a new cytotoxic agent.”

Datavault AI (NASDAQ: DVLT) is highlighted in the Winter 2026 issue (p. 27) of RADIO + TELEVISION BUSINESS REPORT, which examines the company’s patented ADIO technology and real-time bias meter initiative. ADIO leverages embedded, inaudible audio signals to activate mobile viewer responses, enabling live polls, feedback and interactive engagement during broadcast and streamed programming. The publication points to the technology’s pilot deployment with Fintech.TV as an early stage proving ground ahead of broader rollout across streaming and broadcast platforms.

SPACSphere Acquisition (NASDAQ: SSACU) announced the closing of its initial public offering of 17,250,000 units at $10.00 per unit, including 2,250,000 units issued pursuant to the full exercise of the underwriter’s over-allotment option, generating gross proceeds of $172.5 million. The units began trading on the Nasdaq Global Market on Feb. 6, 2026, under the symbol “SSACU,” with underlying Class A ordinary shares, warrants and share rights expected to trade separately as “SSAC,” “SSACW” and “SSACR,” respectively. An amount equal to $10.00 per unit was placed in trust, and the company will seek a merger or similar business combination, focusing on digital assets, technology and healthcare, with D. Boral Capital LLC acting as sole book-running manager.

Wearable Devices (NASDAQ: WLDS) announced the launch of ai6 Labs, a closed-loop ecosystem designed to bridge human intent with digital systems through non-invasive electromyography and its Mudra technology platform. The initiative integrates foundational neural research, commercialization and rapid AI experimentation through three pillars: a foundation layer built on the Large MUAP Model and Brain-AI Bus architecture to decode biological intent into machine-readable data; a revenue and ecosystem growth component aimed at monetizing research outcomes; and an AI accelerator focused on advancing concepts across areas such as agentic workflows and edge AI. Chief Executive Officer Asher Dahan said the launch positions the company to capitalize on accelerating demand for AI wearables, gesture control in extended reality and non-invasive brain-computer interface technologies.

Colombier Acquisition (NYSE: CLBR U) announced the closing of its initial public offering of 29,900,000 units, including 3,900,000 units issued through the underwriters’ over-allotment option, at $10.00 per unit for total gross proceeds of $299 million. Each unit consists of one Class A ordinary share and one-eighth of one redeemable warrant, with whole warrants exercisable at $11.50 per share. The units trade on the New York Stock Exchange under the symbol “CLBR U,” with underlying shares and warrants expected to trade separately as “CLBR” and “CLBR WS.” The company placed $299 million in trust and will seek to complete a merger or similar business combination, with Roth Capital Partners serving as sole book running manager and StoneX Financial Inc. acting as manager.

Renewal Fuels (OTC: RNWF), doing business as American Fusion, announced it has engaged IBN to support its corporate communications strategy following its completed merger with Kepler Fusion Technologies. The company has repositioned its operations toward the development and long-term commercialization of deployable fusion power systems for industrial and infrastructure applications, advancing its technology and deployment roadmap through a wholly owned subsidiary. Under the agreement, IBN will leverage its investor-focused distribution network, including more than 5,000 syndication outlets and InvestorWire services, to expand awareness among investors, journalists and the broader market as Renewal Fuels pursues disciplined governance, intellectual property development and regulatory readiness within a public-company framework.

Datavault AI (NASDAQ: DVLT) announced that Chief Executive Officer Nate Bradley hosted a private, invitation-only dinner Tuesday evening at Mar-a-Lago for institutional investors, high-net-worth individuals and senior government officials, following earlier meetings with a separate group of strategic investors. Discussions focused on the company’s execution roadmap, platform capabilities and long-term positioning in data infrastructure, digital engagement and real-world asset tokenization. The engagements follow recent visibility from Super Bowl LX weekend activations and a stockholder letter highlighting $49 million in fourth-quarter 2025 tokenization and technology licensing agreements, record fiscal 2025 revenue performance, expectations for at least $30 million in fiscal 2025 revenue and plans to report fourth-quarter results on Feb. 15, 2026.

OptimumBank Holdings (NYSE American: OPHC) announced that its management team will host a conference call and live webcast on Wednesday, Feb. 18, 2026, at 10 a.m. ET to discuss financial results for the fourth quarter and full year ended Dec. 31, 2025, and provide a business update. The company released its fourth-quarter and full-year earnings on Feb. 2, 2026, and invited current and prospective investors to register for the webcast, with additional information available by contacting Seth Denison at SDenison@OptimumBank.com

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.

Rail Vision (NASDAQ: RVSN) issued a corporate update from Chief Executive Officer David BenDavid outlining key 2025 milestones and strategic priorities for 2026. The company reported commercial advancements including a MainLine system order from a leading Central American freight operator, a $335,000 follow-on order from a Latin American mining company and expanded collaboration with Israel Railways, which highlighted Rail Vision’s AI technology at CES 2026. Rail Vision also announced a memorandum of understanding with Sujan Industries in India and the launch of a proof-of-concept project there in January 2026. Additionally, the company completed the acquisition of a 51% stake in Quantum Transportation, positioning the firm to integrate quantum computing and AI capabilities into its rail safety platforms as it focuses on converting pilots into deployments, expanding geographically and scaling sales efforts in 2026.

Greenwave Technology Solutions (NASDAQ: GWAV) announced that its board of directors appointed Chelsea Pullano as chief financial officer, effective Feb. 5, 2026. The appointment follows the company’s Jan. 2, 2026, scope of work agreement with MACK Financial Solutions LLC, under which MACK will provide bookkeeping, financial reporting and SEC reporting services, with Pullano serving as part-time CFO. Pullano, co-founder and CEO of MACK since May 2023, previously served as chief financial officer of Creatd Inc. from June 2020 to May 2023 and as director of finance at Lucosky Brookman LLP from September 2024 to March 2025.

Perpetuals.com (NASDAQ: PDC), a fintech company focused on AI-driven digital asset trading solutions and regulated market infrastructure, announced that it has completed a pilot of its BayesShield(TM) artificial intelligence system, indicating that the technology would have successfully filtered out 92% of losing retail trades in Bitcoin perpetual futures based on a year-long backtest of real trading activity ( https://ibn.fm/Vbl3F ).

Mass General Brigham researchers have developed a new AI model that can estimate brain age, assess a patient’s risk of developing dementia, and help predict survival outcomes for brain cancer using routine MRI scans. The system, created within the Harvard-affiliated health network, is designed to pull multiple clinical signals from a single brain image rather than being trained for one narrow diagnostic task.

The market for quantum computing is expected to grow very fast over the next few years, with experts predicting it could reach about $8.7 billion by 2031. This rapid growth shows how important quantum technology is becoming as industries look for more powerful ways to solve complex problems that traditional computers struggle with.

On Monday, gold started the week on a high, closing the day with gains of 2% to put the metal on firm footing after it had climbed to a record high of $5,106 earlier in the day. Silver also registered gains of 7% on the day, reviving expectations that precious metals could be set to regain their upward momentum.

Octane, a Southern California innovation organization, will host its second annual Neuro Tech Forum on March 26–27, 2026, at the VEA Newport Beach. The two-day event is set to bring together investors, physicians, and industry leaders to explore emerging opportunities in neurotechnology. The forum lineup will feature keynote speaker Nick Hopkins, panel discussions on digital health, brain-computer interfaces (“BCI”), neuromodulation, neurovascular innovation, and treatments for neurological and psychiatric disorders, as well as live pitches from six neuroscience and vascular startups. Emceed by Jojo Platt, the forum aims to connect innovative companies with Octane’s network of angel investors, venture capital firms, strategic partners, and medical leaders, while highlighting advances in areas such as endovascular therapies and wearable and implantable BCI technologies.

President Donald Trump’s executive order issued on December 18 signaled a shift in US medical cannabis policy, opening new paths for research and fueling a wave of mergers and acquisitions across the sector. However, one essential issue remains unresolved: how will patients receive medical marijuana in a way that resembles standard healthcare?

Electronic Servitor Publication Network (OTC: XESP), a market disruptor for B2B companies using cutting-edge technology to reach target markets, has developed and is commercializing its Digital Engagement Engine(TM). The solution combines automation, unique data management and microservices architecture to elevate digital content and drive better digital interactions within current and new communities. “The company anchored the development of the Digital Engagement Engine(TM) in data analysis and smart technology, creating a tech stack that can identify even the narrowest of niches within clients’ respective target markets, tailor content to meet their exact needs, and deliver the content to them right when they need it,” a recent article reads. “Remarkably, XESP’s approach is not lifted from the conventional customer experience (‘CX’) playbook; it is rather unique. And as the company’s CEO Peter Hager explained in an interview with Proactive, this uniqueness is responsible for making the company good at what it does. ‘We just took an immense amount of focus on what happens when you’re not face to face with your customers. Many people look at the customer experience as a face-to-face [interaction] or just the brand, but they haven’t really followed the journey of the customer when they’re not face to face,’ explained Hager. XESP resolved to tackle the underlying problem by creating a system that allows client companies to sense and respond to what their users and customers are looking for when interacting with them digitally. This approach, according to Hager, created an edge.”

Lantern Pharma (NASDAQ: LTRN), a clinical-stage biopharmaceutical company leveraging artificial intelligence to accelerate oncology drug discovery and development, announced that Chief Executive Officer and President Panna Sharma will present at the 7th Glioblastoma Drug Development Summit, taking place Feb. 17–19, 2026, in Boston. During a Day Two presentation on Feb. 19, Mr. Sharma will highlight how the Company’s RADR® AI and machine learning platform supported the development of STAR-001, a brain-penetrant therapeutic candidate, including insights into mechanism of action, biomarker identification, indication selection, and novel combination strategies for aggressive CNS cancers such as glioblastoma and ATRT.

Olenox Industries (NASDAQ: OLOX) announced the appointment of Erik Blum and Adam Falkoff to its Board of Directors, effective Feb. 6, 2026. The appointments fill existing board vacancies, with both directors serving until the Company’s 2025 Annual Meeting of Shareholders and participating in the Company’s non-employee director compensation program, as Olenox adds leadership experience spanning public company turnarounds, corporate finance, public policy, and global strategic advisory.

MedWell Ai (OTCQB: MWAI) announced that it has signed a letter of intent to create a vertically integrated health, wellness, and longevity platform organized across three core divisions: national pharma distribution and telemedicine, a nationwide portfolio of surgical, cosmetic, and men’s health centers, and an advanced biologics and product innovation group. The proposed consolidation includes Ageless Cosmetic Surgery Centers, Apollo BioWellness and its biologics subsidiary, and MedWell USA, with the combined company projecting more than $25 million in annual revenue in 2026 based on trailing 2025 revenues of $14 million, assuming successful closings and adequate funding, as parties move forward with due diligence targeting transaction completion within 60 days.

White Pearl Acquisition (NYSE: WPACU) announced that it closed its initial public offering on Feb. 3, 2026, issuing 11,500,000 units at $10.00 per unit, including 1,500,000 units sold pursuant to the full exercise of the underwriters’ over-allotment option. The units began trading on the New York Stock Exchange on Feb. 2, 2026, under the symbol “WPACU,” with each unit consisting of one Class A ordinary share and one right to receive one-fifth of one Class A ordinary share upon completion of an initial business combination, while the Company’s Class A ordinary shares, units, and rights trade under the symbols “WPAC,” “WPACU,” and “WPACR,” respectively, and D. Boral Capital LLC acted as sole bookrunner for the offering.

From lab research to clinical application, photodynamic therapy (“PDT”) is emerging as a powerful treatment approach that uses light and chemistry to selectively target diseased tissue. As this modality gains attention for its precision and safety profile, Soligenix (NASDAQ: SNGX) is developing light-activated therapies designed to treat cutaneous T-cell lymphoma (“CTCL”) and other inflammatory skin diseases using targeted photodynamic mechanisms that aim to improve outcomes while minimizing systemic toxicity.

NanoViricides, Inc. (NYSE American: NNVC), a clinical-stage antiviral developer, announced that it has filed an application with the U.S. Food and Drug Administration Office of Orphan Products Development for Orphan Drug Designation for NV-387 as a treatment for measles. If granted, the designation would make the Company eligible for incentives including tax credits for qualified clinical trials, exemptions from certain FDA user fees, and up to seven years of market exclusivity following approval, supporting the regulatory development of NV-387 amid rising measles cases in the United States and globally.

This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising.

Perpetuals.com (NASDAQ: PDC), a fintech company focused on AI-driven digital asset trading solutions and regulated market infrastructure, is positioning itself at the intersection of traditional financial infrastructure and blockchain-based systems, targeting institutions that want exposure to digital assets without stepping outside regulated frameworks. The company develops software that allows regulated trading venues to operate continuously, with self-clearing and blockchain-native settlement replacing legacy post-trade processes.

VolitionRx (NYSE American: VNRX), a multi-national epigenetics company, announced the appointment of Medical & Biological Laboratories Co. Ltd. as a non-exclusive distributor of its Nu.Q(R) Discover assays in Japan. The agreement expands access to Volition’s nucleosome-based biomarker assays for drug developers and researchers in the Japanese market and builds on the Company’s growing global collaborator network, as Nu.Q(R) Discover now serves close to 100 clients worldwide, including leading pharmaceutical and diagnostic companies using the assays to support disease research, drug development, and late-stage clinical trials.

This article has been disseminated on behalf of Lahontan Gold Corp. and may include paid advertising.

This article has been disseminated on behalf of Helus Pharma and may include paid advertising.

Perpetuals.com (NASDAQ: PDC) announced the launch of Barrier Futures, a proprietary, MiFID II-compliant derivatives product designed as a regulated alternative to offshore perpetual futures and retail contracts for difference, addressing markets that collectively represent multi-hundred-trillion dollars in annual notional volume. The Company said Barrier Futures offer defined-risk positions without margin calls while enabling brokers to participate through a scalable B2B model that includes trading fee revenue shares, spread participation, and white-label licensing, with the platform expected to go live for qualified brokers in March 2026 and initial partnerships targeted for Q1.

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising.

As an abundant element in the universe, hydrogen has an extensive range of applications, among them its use as a carrier of clean energy in fuel cells in cars and in oil refining. With the automotive industry continuously expanding, the demand for alternative fuels like hydrogen has grown exponentially.

China has begun producing sodium-ion electric vehicles, moving ahead of Western automakers like Tesla and opening the door to a new category of EVs. CHANGAN Automobile recently unveiled an electric passenger car powered by a sodium-ion battery supplied by CATL, with volume production expected to begin later this year.

While people have been quick to blame health insurers for the skyrocketing cost of health care in the U.S., the reality of the situation is more nuanced, and other factors have played a much bigger role in driving up costs. We explore some of those less-reported drivers of the high cost of health care in the country.

Military flight training has long followed a familiar formula: structured lessons, carefully staged challenges, and instructors judging progress only by performance. In the Netherlands, researchers are now testing a system that could change that model by allowing simulators to respond directly to what is happening inside a pilot’s brain .

Earth Science Tech (OTC: ETST), a strategic holding company focused on acquiring and scaling high-potential operating businesses, announced that it will report financial results for the three months ended Dec. 31, 2025, after the close of trading on Tuesday, Feb. 17, 2026.

A new analysis shows that roughly 90% of China’s investment growth last year came from green energy, underscoring how decisively clean industries now drive the country’s economic expansion. According to research from the Center for Research on Energy and Clean Air published by Carbon Brief , clean energy sectors propelled more than 90% of capital growth in 2025 and now rival all but seven national economies in scale.

Concerns about China’s stance on digital assets have resurfaced as Bitcoin drifts deeper into bear market conditions. Chinese authorities have announced a tighter interpretation of their existing cryptocurrency ban, moving to explicitly outlaw activities tied to real-world asset (RWA) tokenization and unapproved stablecoins tied to the yuan.

On Friday, China launched an experimental reusable spacecraft in a mission that was shrouded in secrecy like the previous three such launches. Announcements about this mission were reported by Xinhua, a state-run media organization.

Forward Industries (NASDAQ: FWDI) the leading Solana treasury company, announced that it will host a conference call on Thursday, Feb. 12, 2026, at 5 p.m. Eastern Time to discuss its financial and operating results for the three months ended Dec. 31, 2025, with financial results to be released in a press release prior to the call; the Company’s executive team will host the call and webcast presentation, followed by a question-and-answer period.

Ohio Attorney General Dave Yost has approved the official title and summary language for a proposed referendum that seeks to roll back the state’s recent changes to its recreational marijuana laws. The decision clears a major procedural hurdle for advocates who want voters to weigh in on Senate Bill 56, a measure adopted by lawmakers late last year.

XTI Aerospace (NASDAQ: XTIA), an aerospace technology company focused on scaling its Drone Nerds, LLC subsidiary, outlined its operating leverage, expanding customer base, and near-term value creation initiatives during its Shareholder Town Hall held Feb. 5, 2026. Management provided full-year 2026 revenue guidance for the first time, projecting revenue to exceed $160 million, representing approximately 30% growth, and emphasized disciplined execution following the November 2025 acquisition of Drone Nerds, which has positioned the Company as a scaled enterprise drone and unmanned aircraft systems platform serving enterprise, government, and defense-adjacent customers.

Safe Pro Group Inc. (NASDAQ: SPAI), a developer of AI-powered defense and security solutions, is presenting at the 2026 Defence Leaders Combat Engineer & Logistics Conference (“CEL26”) in Krakow, Poland ( https://ibn.fm/u4HK9 ).

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, recently acquired Liora Technologies, a company that’s pioneering proton therapy systems for treating tumors in various types of cancers.

Solowin Holdings (NASDAQ: AXG), a financial technology firm bridging traditional and digital assets, announced a partnership with Taobao Shangou, a subsidiary of Alibaba Group, and Hangzhou Bossen to deploy an integrated model combining high-quality carbon assets, consumer platform incentives, and on-chain carbon credit circulation. The collaboration leverages AXG’s Ferion asset tokenization platform to enable compliant, transparent lifecycle management of carbon assets, which are embedded into Taobao Shangou’s consumer incentive system to reward users for low-carbon behaviors such as green delivery and sustainable purchasing choices, supporting China’s national and provincial carbon peaking and carbon neutrality objectives and establishing a scalable framework for inclusive carbon reduction.

Oragenics (NYSE American: OGEN), a clinical-stage biotechnology company developing brain-targeted therapeutics using proprietary intranasal delivery technology, today outlined targeted milestones for 2026 as it advances ONP-002, a novel intranasal neurosteroid, toward Phase 2 clinical development. The Company is preparing to initiate a Phase 2a clinical trial of ONP-002 in Australia for the treatment of concussion and mild traumatic brain injury (mTBI), positioning the candidate as a potential first-in-class pharmacological therapy for a large and underserved global market following positive preclinical and Phase 1 safety and efficacy results.

Renewal Fuels (OTC: RNWF), also known as American Fusion, announced the appointment of Dr. John E. Brandenburg, Ph.D., as chief technology officer of Kepler Fusion Technologies, effective immediately. Dr. Brandenburg is a senior plasma physicist with more than four decades of experience spanning fusion energy, advanced propulsion, and applied plasma physics, and brings deep technical expertise to the Company’s mission of commercializing its Texatron(TM) aneutronic fusion platform. His career includes senior scientific roles at Lawrence Livermore National Laboratory, Sandia National Laboratories, The Aerospace Corporation, the Florida Space Institute at Kennedy Space Center, and Orbital Technologies Corporation, along with service under multiple U.S. government security clearances supporting sensitive defense and energy research programs.

Investors are responding positively to Meta’s decision to keep increasing artificial intelligence spending, even as fears grow that the AI boom could be inflating a bubble . While concerns about a potential bust are becoming more common, Meta’s latest earnings suggest that, for now, the market is still willing to back heavy investment, particularly when it produces clear financial results.

The cryptocurrency market is once again under pressure as prices continue to fall, and experts are warning that the pain may not be over yet. Bitcoin and Ethereum, the two largest digital assets, have both recorded sharp losses, raising concerns among traders, investors, and analysts worldwide.

Disseminated on behalf of Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) and may include paid advertising.

ParaZero Technologies (NASDAQ: PRZO), an aerospace defense company developing smart, autonomous solutions for manned and unmanned aerial systems, announced its participation in Enforce Tac 2026, Germany’s leading trade fair for security and defence, taking place Feb. 23–25, 2026, at the Exhibition Centre Nuremberg. ParaZero will exhibit its DefendAir counter-UAS systems within the Israeli National Pavilion, organized by the Israel Export Institute, highlighting its multi-layered, non-explosive drone interception technology and supporting the Company’s strategy to expand its European footprint following successful demonstrations to German law enforcement and senior NATO officials in late 2025.

Wisconsin Democratic lawmakers recently introduced legislation that would legalize marijuana for both recreational and medical use, renewing a long-running debate as the state continues to lag behind nearby Midwestern neighbors on cannabis policy. Michigan and Illinois already permit recreational cannabis, while Minnesota has moved in the same direction. Wisconsin, by contrast, still treats most marijuana possession as a crime.

Disseminated on behalf of Fairchild Gold Corp. (TSX.V: FAIR) (OTCQB: FCHDF) and may include paid advertising.

Disseminated on behalf of Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) and may include paid advertising.

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, is leading efforts in addressing some of the pressing challenges in cancer treatment. “Instead of developing standalone cancer drugs, the company is adopting a different strategy aimed at enhancing the overall effectiveness of existing immunotherapy and chemotherapy regimens through a novel biological target,” reads a recent article. “LIXTE’s platform is built on its proprietary LB-100 compound, a one-of-a-kind inhibitor of Protein Phosphatase 2A (‘PP2A’). PP2A is a critical enzyme involved in various cellular processes, including cell growth regulation, DNA repair, and modulation of the immune response. Through the selective inhibition of PP2A, LB-100 is strategically designed to make cancer cells more treatable while also boosting the body’s immunity to tumors… This strategic approach is important because resistance and limited efficacy are major impediments in oncology. Different cancers fail to respond adequately to immunotherapy. The company’s strategy is not aimed at replacing these therapies, but rather at improving them, making it possible for standard treatments to work for more patients.”

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, is leading efforts in addressing some of the pressing challenges in cancer treatment. “Instead of developing standalone cancer drugs, the company is adopting a different strategy aimed at enhancing the overall effectiveness of existing immunotherapy and chemotherapy regimens through a novel biological target,” reads a recent article. “LIXTE’s platform is built on its proprietary LB-100 compound, a one-of-a-kind inhibitor of Protein Phosphatase 2A (‘PP2A’). PP2A is a critical enzyme involved in various cellular processes, including cell growth regulation, DNA repair, and modulation of the immune response. Through the selective inhibition of PP2A, LB-100 is strategically designed to make cancer cells more treatable while also boosting the body’s immunity to tumors… This strategic approach is important because resistance and limited efficacy are major impediments in oncology. Different cancers fail to respond adequately to immunotherapy. The company’s strategy is not aimed at replacing these therapies, but rather at improving them, making it possible for standard treatments to work for more patients.”

Soligenix (NASDAQ: SNGX) was featured in a recent article that discussed the company’s release of positive top-line results from its phase 2 clinical trial evaluating SGX945 for the treatment of aphthous ulcers associated with Behçet’s. “Behçet’s disease is a rare, chronic inflammatory condition that can cause recurrent, painful ulcers, eye inflammation and systemic complications that significantly affect quality of life. Because available treatments are limited and often inconsistent, clinical trial updates in this disease area carry particular importance. Soligenix is reporting results from a phase 2a proof of concept study evaluating its investigational therapy, SGX945 (dusquetide), for the treatment of Behçet’s disease, representing a notable step forward in efforts to improve care for patients with this underserved condition… SGX945 is a novel innate defense regulator designed to modulate the body’s immune response rather than broadly suppress it. Soligenix explains that this mechanism aims to reduce harmful inflammation while preserving the immune system’s ability to fight infection, a critical distinction from many existing immunosuppressive therapies. In the phase 2 study, SGX945 was reported to be safe and well tolerated, an important consideration for a chronic disease requiring repeated or long-term treatment.”

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising.

As investor interest in advanced technology platforms grows alongside breakthroughs in research, materials science and data-driven innovation, Xeriant (OTCQB: XERI) is shaping a strategy that extends well beyond any single product or material solution. Rather than positioning itself as a one-technology company, Xeriant is increasingly defining its identity around building an integrated innovation ecosystem focused on accelerating discovery, development and commercialization of high-impact technologies, including nanotech.

Labor volatility has become one of the most persistent structural challenges facing the hospitality industry. Even as demand has returned across hotels, venues, and resorts, staffing shortages, call offs, and physical strain on frontline workers continue to pressure margins and service consistency. Rather than replacing workers outright, operators are increasingly exploring automation models that function as workforce support, reducing friction in day-to-day operations while preserving the human element that defines hospitality.

SKYX Platforms (NASDAQ: SKYX) announced the launch of its newly patented all-in-one ceiling plug & play SKYFAN & Turbo Heater at Home Depot, including the debut of a dedicated SkyPlug branding page for the product and other plug & play offerings on HomeDepot.com. The Home Depot launch is expected to support increased visibility, consumer education, and demand throughout fiscal year 2026 as the company expands penetration across professional and retail channels. The SKYFAN & Turbo Heater combines a ceiling fan with an integrated turbo heater to provide year-round heating and cooling while improving safety, efficiency, and space utilization compared with traditional portable heaters. SKYX also said it plans to expand variations, finishes, and additional SKUs in response to early demand and retailer engagement, with production underway through its manufacturing partners.

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) and may include paid advertising.

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising.

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising.

Nightfood Holdings (OTCQB: NGTF) was featured in a NetworkNewsAudio Audio Press Release examining how automation is reshaping service speed and revenue capture in high-traffic hospitality environments such as stadiums, conventions and live events. The editorial highlights how demand surges during narrow service windows can directly limit revenue when labor is insufficient, positioning automation as a present-day operational necessity rather than a future concept. Through its AI robotics strategy and TechForce Robotics subsidiary, Nightfood is presented as an infrastructure-focused solution provider designed to operate in high-volume settings, increase throughput and convert peak-demand congestion into measurable revenue rather than lost opportunity.

Rail Vision (NASDAQ: RVSN) announced that it has advanced to the next phase of its collaboration with Israel Railways, moving forward with a one-month evaluation pilot of its ShuntingYard system following a successful initial capability demonstration. The advancement builds on Israel Railways prior purchase and installation of Rail Vision MainLine systems and will evaluate ShuntingYard performance under local operating conditions to gather detailed operational feedback from the cargo team. Designed for stop-and-go rail yard environments, the ShuntingYard product combines electro-optical sensors and real-time AI to provide continuous situational awareness in low-light and adverse weather conditions. Upon successful completion of the pilot, Rail Vision and Israel Railways plan to explore deployment options aimed at improving safety, operational efficiency, and maintenance cost savings.

Disseminated on behalf of Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) and may include paid advertising.

Gold recorded a powerful start to the year, climbing by over 13% an ounce last month. This makes it its strongest monthly performance since the late 90s. The precious metal’s rally was driven by a mix of geopolitical uncertainty and shifting macroeconomic expectations.